Randomized Controlled Trials 6: On Contamination and Estimating the Actual Treatment Effect
- 30 January 2015
- book chapter
- Published by Springer Nature
- Vol. 1281, 249-259
Abstract
The intention-to-treat analysis is the gold standard for evaluating efficacy in a randomized controlled trial. However, when non-adherence to randomized treatments is high, the actual treatment effect may be underestimated. The impact of drop-out from the intervention group or drop-in to the control group may be controlled by trial design, increasing the sample size, effective study execution, and a prespecified analytical plan to take contamination into account. These analyses may include censoring at time of co-interventions associated with stopping treatment, lag censoring which allows an additional period after discontinuation of study treatment to account for residual treatment effects, inverse probability of censoring weights (IPCW), accelerated failure time models, and contamination adjusted intent-to-treat analysis. These methods are particularly useful in assessing the “prescribed efficacy” of the study treatment, which can aid clinical decision-making.Keywords
This publication has 12 references indexed in Scilit:
- Effect of Cinacalcet on Cardiovascular Disease in Patients Undergoing DialysisNew England Journal of Medicine, 2012
- Assessing methods for dealing with treatment switching in randomised controlled trials: a simulation studyBMC Medical Research Methodology, 2011
- Intention-to-treat concept: A reviewPerspectives in Clinical Research, 2011
- An IV for the RCT: using instrumental variables to adjust for treatment contamination in randomised controlled trialsBMJ, 2010
- Estimating effects from randomized trials with discontinuations: the need for intent-to-treat design and G-estimationClinical Trials, 2008
- Evaluation of Cinacalcet Therapy to Lower Cardiovascular Events (EVOLVE)Clinical Journal of the American Society of Nephrology, 2007
- Informative noncompliance in endpoint trialsCurrent Controlled Trials in Cardiovascular Medicine, 2004
- Estimating a treatment effect in survival studies in which patients switch treatmentStatistics in Medicine, 2002
- Marginal Structural Models to Estimate the Causal Effect of Zidovudine on the Survival of HIV-Positive MenEpidemiology, 2000
- Correcting for Noncompliance and Dependent Censoring in an AIDS Clinical Trial with Inverse Probability of Censoring Weighted (IPCW) Log‐Rank TestsBiometrics, 2000